Homologous recombination is a conserved pathway for the repair of DSBs, with Rad51 postulated to play a central role (Cox, 1999; Pâ ques and Haber, 1999). In mammals, as in other organisms, homology-directed Summary repair (HDR) of a DSB maintains genomic integrity through precise repair by gene conversion, using the The BRCA2 tumor suppressor has been implicated in the maintenance of chromosomal stability through a sister chromatid as a repair template (Johnson and Jasin, 2000). Nonhomologous repair mechanisms also function in DNA repair. In this report, we examine human and mouse cell lines containing different BRCA2 play a major role in the repair of DSBs in mammalian cells, although this type of repair is generally thought mutations for their ability to repair chromosomal breaks by homologous recombination. Using the I-SceI to be imprecise and potentially more mutagenic (Jeggo, 1998). BRCA1-deficient cells have recently been demonendonuclease to introduce a double-strand break at a specific chromosomal locus, we find that BRCA2 strated to have impaired HDR of a chromosomal DSB, whereas nonhomologous repair was not diminished mutant cell lines are recombination deficient, such that homology-directed repair is reduced 6-to Ͼ100-(Moynahan et al., 1999). A similar role for BRCA2 as a caretaker of genomic stability would suggest that fold, depending on the cell line. Thus, BRCA2 is essential for efficient homology-directed repair, presumably BRCA2 inactivation could foster tumorigenesis by increasing the likelihood that cells would accrue mutain conjunction with the Rad51 recombinase. We propose that impaired homology-directed repair caused tions in genes that control cell division, death, or life span. by BRCA2 deficiency leads to chromosomal instability and, possibly, tumorigenesis, through lack of repair
Introduction cells carrying different BRCA2 mutations have a diminished capacity to repair a chromosomal DSB by gene Germline mutations in either of the breast cancer susceptibility genes BRCA1 or BRCA2 predispose to breast, conversion. These findings establish a biological function for BRCA2 that is relevant to carcinogenesis. ovarian, and other cancers (Rahman and Stratton, 1998). Inheritance of one defective allele of either gene is sufficient to confer cancer predisposition, but tumors from Results predisposed individuals consistently exhibit loss of heterozygosity, implying that the BRCA1 and BRCA2 gene BRCA2-Deficient CAPAN-1 Cells Are Defective in HDR products act as tumor suppressors. Both genes encode
The human pancreatic adenocarcinoma cell line, large nuclear proteins whose function in tumor suppres-CAPAN-1, carries a 6174delT mutation on one allele of sion has been a matter of speculation, although roles BRCA2 with loss of the wild-type BRCA2 allele (Goggins in both DNA repair and transcription have been ascribed et al., 1996). This frameshift mutation, which is frequent (Welcsh et al., 2000) . at a frequency of 12% of the electroporated cells (data not shown), and then declined 5 days after transfection to an average of 4% (Table 1) . We can surmise, therefore, and as a result will undergo a DSB when I-SceI is exthat HDR is occurring in approximately 1 per 1400 cells pressed in vivo. The I-SceI site was incorporated at a successfully transfected with the I-SceI expression vecBcgI restriction site by substituting 11 bp of wild-type tor, based on a 12% transfection efficiency and an aver-GFP sequences with those of the I-SceI site. These subage frequency of recombination of 0.0086%. stituted base pairs also introduce two in-frame stop We have typically found that a DSB introduced into codons. Downstream of SceGFP is an 812 bp internal the genome of rodent cells within the DR-GFP substrate GFP fragment (iGFP) that can be used to correct the leads to as much as a three order-of-magnitude inducmutation in the SceGFP gene to result in a GFPϩ gene. Figure 2B ; data not shown). Multiple digests were performed to when analyzing the functional role of gene products in tumor-derived cell lines, we examined the role of BRCA2 confirm that the integrated recombination substrate was a single copy, and that no gross changes in the integrity in a more genetically defined system. For this, we used murine embryonic stem (ES) cells containing hypomorof the reporter substrate had occurred prior to integration (data not shown). phic Brca2 alleles. In addition to the conserved internal BRC repeats, a second Rad51-interacting domain was To detect HDR of an induced chromosomal DSB, the I-SceI expression vector pCBASce was transiently transidentified at the C terminus of the mouse Brca2 protein tors (see Figure 3A) . In these vectors, the selectable hygromycin resistance gene (hyg R )-coding sequences We first performed gene targeting assays with the Brca2 lex1/lex2 ES cells to determine their ability to homoloare fused in-frame to pim1-coding sequences, such that 
Brca2
lex1/lex2 ES cells, HDR is reduced 5-to 6-fold relative to wild-type ES cells. Thus, the severity of the defect was significantly greater in cells that express a highly truncated BRCA2 protein than in cells in which only the most C-terminal Rad51-interacting domain is perturbed. Gene targeting as assayed in the mouse cells was also reduced.
Although BRCA1 and BRCA2 show no homology, the two genes share several characteristics aside from a predisposition to breast and ovarian cancer when mutated. For example, disruptions of Brca1 and Brca2 in the mouse lead to early embryonic lethality, and both 
